Nico Saraceno

In an increasingly interconnected and complex pharmaceutical supply chain, achieving E2E visibility is no longer a luxury—it's a necessity. This keynote explores how advanced technologies, such as AI, IoT, and blockchain, are enabling organizations to gain real-time insights, mitigate risks, and improve decision-making. Learn how leveraging data can enhance supply chain transparency, streamline operations, and ultimately ensure better patient outcomes. Key takeaways include:  

• Discover how real-time data and digital tools are transforming supply chain visibility and reducing operational blind spots 
• Learn strategies to proactively identify risks and inefficiencies to ensure a seamless flow of products and information 
• Explore best practices for collaborating with partners and leveraging technology to achieve a transparent, patient-centric supply chain 

In an era where remarkable advancements are revolutionizing patient care, the healthcare supply chain must evolve to meet the unique barriers these innovations bring. Featuring Ammie McAsey, SVP of Supply Chain Operations, McKesson, along with Don Sawyer, SVP of Market Access, Regeneron, and Dr. Leslie Busby, SVP & Chief Medical Officer, US Oncology Network, the panel discussion will delve into the interconnected roles of all stakeholders in shaping a future-ready supply chain. The session will tackle key obstacles such as the role of a modernized supply chain in mitigating drug shortages, scaling the supply chain to meet growing demands in larger patient populations, as well as explore opportunities to ensure efficient and secure delivery from manufacturer to patient.

• Identify how advanced therapies are challenging traditional supply chain models and what adaptations are required
• Explore cross-functional strategies to scale delivery infrastructure and reach growing patient populations
• Understand the importance of end-to-end visibility, real-time data, and collaboration in reducing disruption and ensuring continuity of care